Takeda's Oncology Discovery Strategy

Author： DeSchuytner Brian   Kuvalanka Kyle   Hibner Barbara   Bolen Joseph  

Publisher： Oxford University Press

ISSN： 1465-3621

Source： Japanese Journal of Clinical Oncology, Vol.43, Iss.4, 2013-04, pp. : 357-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Urologic oncology: extraordinary opportunities for discovery - New initiatives in radiation oncology

By Coleman C.N.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 5, 2001-09 ,pp. : 185-188

Elsevier

Access to resources Recommend Favorite

The Value of Banked Samples for Oncology Drug Discovery and Development

By Shaw Peter M.   Patterson Scott D.  

Journal of the National Cancer Institute Monographs, Vol. 2011, Iss. 42, 2011-01 ,pp. : 46-49

Oxford University Press

Access to resources Recommend Favorite

EORTC Scientific strategy meeting 25-26 March 1999 - a quality-of-life instrument for use in international clinical trials in oncology

By Meunier F.   Horiot J.-C.  

European Journal of Cancer, Vol. 35, Iss. 10, 1999-10 ,pp. : 1423-1430

Elsevier

Access to resources Recommend Favorite

Retinoids in Oncology

By Aapro M.S.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 834-835

Elsevier

Access to resources Recommend Favorite

Hyperthermia in oncology

By Falk M. H.   Issels R. D.  

International Journal of Hyperthermia, Vol. 17, Iss. 1, 2001-01 ,pp. : 1-18

Informa Healthcare

Access to resources Recommend Favorite